Dow to shut 3 US ethylene plantsDow Chemical is closing three US manufacturing plants, including an ethylene production unit in Hahnville, Louisiana in a further bid to expand its specialty chemicals business. Pharma: people on the movein-PharmaTechnologist presents its latest round up of appointments in the pharmaceutical sector, including the new president of Sanofi-Aventis France. Lantus cancer link research flawed says Sanofi; mulls R&D restructuringSanofi-Aventis has moved to defend its long-acting diabetes treatment Lantus (insulin glargine) and says that recent research linking it to the development of cancer is of “poor quality.” PSI collaborates with MicrofluidicsParticle Sciences (PSI) is aiming to advance its contract processing offering by collaborating with Microfluidics and sharing formulation and nanotechnology expertise. |
News in brief
|
|
Medidata has followed up its successful IPO by inking a deal with Roche, which is reported to be pulling out of PhRMA and the ABPI, to provide the Swiss pharma with an enterprise-wide electronic EDC system.
UK contracting group Pharmaceutical Development Services (PDS) has set up an office in North Carolina, US to court North America pharma firms for the European development sector.
UK group Chiltern International has opened an office in Budapest Hungary, joining the growing number of CRO players to set up in the CEE.
Covance has doubled the capacity for large-scale, long-term stability and release programmes at its facility in Madison, Wisconsin, US.
|
|
Globalisation
More news |
|
|
Lifecycle management
More news |
|
|
Counterfeiting
More news |
|
|
Mergers and acquisitions
More news |